BDBM563234 (2S,4R)-1-(2-(3- acetyl-5- ((3aR,7aS)- hexahydro-H- isoindol-2(3H)-yl)- 1H-indazol-1- yl)acetyl)-N-(2'- chloro-2-fluoro- [1,1'-biphenyl]-3- yl)-4- fluoropyrrolidine-2- carboxamide::US11407738, Example 00409

SMILES CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)N1C[C@H]2CCCC[C@H]2C1

InChI Key InChIKey=RFRPQSVYEWXECX-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 563234   

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM563234(US11407738, Example 00409 | (2S,4R)-1-(2-(3- acety...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent